None
Conditions
Interventions
Experimental group:Remimazolam is used as a sedative drug during bronchoscopy
Control group:Propofol as a sedative drug for use during bronchoscopy procedures
Sponsors
Xiamen Cardiovascular Hospital of Xiamen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have had their ventilators removed after cardiac surgery; 2. Age: 18 - 80 years old; 3. Postoperative pulmonary imaging indicates atelectasis; 4. American Society of Anesthesiologists (ASA) classification I - II; 5. Poor expectoration effect, hypoxemia; 6. Unexplained fever, search for infection source.
Exclusion criteria
Exclusion criteria: 1. Combined with severe liver and kidney dysfunction; 2. Those with severe coagulation dysfunction, bleeding tendency or active massive hemoptysis; 3. Those with full stomach or gastrointestinal obstruction and retention of gastric contents; 4. Those with extremely unstable circulatory and respiratory systems that are not under control; 5. American Society of Anesthesiologists (ASA) classification greater than or equal to grade III. 6. Those who need to change the sedation method during the examination for various reasons; 7. Those whose examination is prematurely terminated for various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful sedation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The time of onset of sedation;Patient satisfaction score ;Recovery time after sedation ; | — |
Countries
China
Contacts
Public ContactXie Junhao
Xiamen Cardiovascular Hospital of Xiamen University
Outcome results
None listed